Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging

Husam Bensreti, Dima W. Alhamad, Alejandro Marrero Gonzalez, Manuel Pizarro-Mondesir, Wendy B. Bollag, Carlos M. Isales, Meghan E. McGee-Lawrence

Research output: Contribution to journalReview articlepeer-review

Abstract

Purpose of Review: Bone marrow adipose tissue (BMAT) in the skeleton likely plays a variety of physiological and pathophysiological roles that are not yet fully understood. In elucidating the complex relationship between bone and BMAT, glucocorticoids (GCs) are positioned to play a key role, as they have been implicated in the differentiation of bone marrow mesenchymal stem cells (BMSCs) between osteogenic and adipogenic lineages. The purpose of this review is to illuminate aspects of both endogenous and exogenous GC signaling, including the influence of GC receptors, in mechanisms of bone aging including relationships to BMAT. Recent Findings: Harmful effects of GCs on bone mass involve several cellular pathways and events that can include BMSC differentiation bias toward adipogenesis and the influence of mature BMAT on bone remodeling through crosstalk. Interestingly, BMAT involvement remains poorly explored in GC-induced osteoporosis and warrants further investigation. Summary: This review provides an update on the current understanding of the role of glucocorticoids in the biology of osteoblasts and bone marrow adipocytes (BMAds).

Original languageEnglish (US)
JournalCurrent Osteoporosis Reports
DOIs
StateAccepted/In press - 2022

Keywords

  • BMAd
  • BMAT
  • BMSC
  • Dexamethasone
  • Glucocorticoid
  • Osteoporosis

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism

Fingerprint

Dive into the research topics of 'Update on the Role of Glucocorticoid Signaling in Osteoblasts and Bone Marrow Adipocytes During Aging'. Together they form a unique fingerprint.

Cite this